Homozygous Familial Hypercholesterolemia (HoFH)
Symptoms, Doctors, Treatments, Advances & More

Homozygous Familial Hypercholesterolemia (HoFH) Overview

Save information for later
Sign Up

Learn About Homozygous Familial Hypercholesterolemia (HoFH)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Homozygous Familial Hypercholesterolemia (HoFH) Local Doctors?
Elite in Homozygous Familial Hypercholesterolemia (HoFH)
Endocrinology
Elite in Homozygous Familial Hypercholesterolemia (HoFH)
Endocrinology

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
Languages Spoken:
English
Offers Telehealth

Paul Duell is an Endocrinologist practicing medicine in Portland, Oregon. Dr. Duell is rated as an Elite provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Familial Hypercholesterolemia, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Heterozygous Familial Hypercholesterolemia (HeFH).

Advanced in Homozygous Familial Hypercholesterolemia (HoFH)
Pediatrics | Pediatric Cardiology
Advanced in Homozygous Familial Hypercholesterolemia (HoFH)
Pediatrics | Pediatric Cardiology

Atrium Health Levine Children's HEARTest Yard Congenital Heart Center

1001 Blythe Blvd., Suite 500, 
Charlotte, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jacob Hartz is a Pediatrics specialist and a Pediatric Cardiologist practicing medicine in Charlotte, North Carolina. Dr. Hartz is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Defective Apolipoprotein B-100, Familial Hypertriglyceridemia, and Pacemaker Implantation. Dr. Hartz is board certified in American Board Of Pediatrics, Pediatric Cardiology and American Board Of Pediatrics/Pediatric Cardiology, Pediatrics. Dr. Hartz is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Homozygous Familial Hypercholesterolemia (HoFH)
Elite in Homozygous Familial Hypercholesterolemia (HoFH)
Johannesburg, GT, ZA 

Frederick Raal practices practicing medicine in Johannesburg, South Africa. Mr. Raal is rated as an Elite expert by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Homozygous Familial Hypercholesterolemia (HoFH), Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, and High Cholesterol.

What are the latest Homozygous Familial Hypercholesterolemia (HoFH) Clinical Trials?
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

Summary: This repository will establish for the first time a system to carefully assess and monitor over time the general health and the amount of cholesterol in the arteries of U.S. children and adults with homozygous familial hypercholesterolemia (hoFH). Patients with this very rare disorder have very high blood levels of cholesterol from birth due to the inheritance of an abnormal gene from each parent....

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicenter, Dose-exploration, Open-label Phase II Study to Evaluate the Efficacy and Safety of EDP167 in Adult Patients With Homozygous Familial Hypercholesterolaemia

Summary: EDP167 is a double-stranded small interfering RNA (siRNA) drug targeting angiopoietin-like 3 protein (ANGPTL3), which may bring benefits for patients with dyslipidemia conditions. This is a dose exploration study in Homozygous Familial Hypercholesterolaemia (HoFH) patients to evaluate the efficacy and safety and pharmacokinetics (PK)/pharmacodynamics (PD) profiles of multiple EDP167 injections.